etoposide has been researched along with Vulvar Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bamberg, M; Eckert, F; Fehm, T; Müller, AC | 1 |
Basgul, A; Bozkurt, N; Eren, FT; Gokaslan, H; Kavak, ZN | 1 |
Mori, H; Niwa, K; Onogi, K; Tamaya, T; Wu, Y | 1 |
Amo-Takyi, BK; Boabang, P; Kohlhagen, H; Kurbacher, CM; Waida, A | 1 |
Beecham, J; Blessing, JA; DiSaia, PJ; Slayton, RE | 1 |
Grönroos, M; Kangas, L; Mäenpää, J | 1 |
6 other study(ies) available for etoposide and Vulvar Neoplasms
Article | Year |
---|---|
Small cell carcinoma of vulva: curative multimodal treatment in face of resistance to initial standard chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Radiography; Tomography, Emission-Computed; Vulvar Neoplasms | 2010 |
Primary yolk sac tumor (endodermal sinus tumor) of the vulva: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Vulvar Neoplasms | 2006 |
Primary endodermal sinus tumor of the vulva in a 52-year-old woman with long-term survival: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Middle Aged; Survivors; Vulvar Neoplasms | 2007 |
Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Female; Humans; Luminescent Measurements; Paclitaxel; Topotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2000 |
Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms | 1987 |
Predictive testing of vulvar and cervical cancers to chemotherapy by the subrenal capsule assay.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Kidney; Methotrexate; Mice; Middle Aged; Neoplasm Transplantation; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1985 |